Glyco-therapy provides comprehensive and customized glycosylation conjugation services for clients in the early stages of research and development. The company also offers early-stage R&D services such as ADC product design, preparation, validation, and evaluation, supporting clients in the development of PCC products.

Glyco-therapy will engage in services and collaborations with partners in the pharmaceutical field through various approaches, including collaborative development and technology platform licensing, to assist in the development of next-generation antibody-drug conjugates.